<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Clin Interv Aging</journal-id>
      <journal-title-group>
        <journal-title>Clinical Interventions in Aging</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1176-9092</issn>
      <issn pub-type="epub">1178-1998</issn>
      <publisher>
        <publisher-name>Dove Medical Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">20396632</article-id>
      <article-id pub-id-type="pmc">2854049</article-id>
      <article-id pub-id-type="publisher-id">cia-5-031</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Adrenal incidentaloma: a case of carcinoma</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ruotolo</surname>
            <given-names>Giovanni</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cia-5-031">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ambrosio</surname>
            <given-names>Maria Raffaella</given-names>
          </name>
          <xref ref-type="aff" rid="af5-cia-5-031">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Caroleo</surname>
            <given-names>Patrizia Rosa</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cia-5-031">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bonacci</surname>
            <given-names>Elvira</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cia-5-031">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Condito</surname>
            <given-names>Anna Maria</given-names>
          </name>
          <xref ref-type="aff" rid="af2-cia-5-031">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Merante</surname>
            <given-names>Alfonso</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cia-5-031">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Arcuri</surname>
            <given-names>Pierpaolo</given-names>
          </name>
          <xref ref-type="aff" rid="af3-cia-5-031">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rocca</surname>
            <given-names>Bruno Jim</given-names>
          </name>
          <xref ref-type="aff" rid="af5-cia-5-031">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Palermo</surname>
            <given-names>Bianca Virginia</given-names>
          </name>
          <xref ref-type="aff" rid="af4-cia-5-031">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Palermo</surname>
            <given-names>Saverio</given-names>
          </name>
          <xref ref-type="aff" rid="af4-cia-5-031">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gareri</surname>
            <given-names>Pietro</given-names>
          </name>
          <xref ref-type="aff" rid="af6-cia-5-031">6</xref>
          <xref ref-type="corresp" rid="c1-cia-5-031"/>
        </contrib>
      </contrib-group>
      <aff id="af1-cia-5-031"><label>1</label>Head Physician Geriatric Unit,</aff>
      <aff id="af2-cia-5-031"><label>2</label>Emergency Medicine Unit,</aff>
      <aff id="af3-cia-5-031"><label>3</label>Division of Radiology,</aff>
      <aff id="af4-cia-5-031"><label>4</label>Nuclear Medicine Unit, &#x201C;Pugliese-Ciaccio&#x201D; Hospital, Catanzaro, Italy;</aff>
      <aff id="af5-cia-5-031"><label>5</label>Department of Human Pathology and Oncology, Pathological Anatomy Section, University of Siena, Siena, Italy;</aff>
      <aff id="af6-cia-5-031"><label>6</label>Elderly Health Care, ASP Catanzaro, Catanzaro, Italy</aff>
      <author-notes>
        <corresp id="c1-cia-5-031">Correspondence: Pietro Gareri, Elderly Health Care, ASP Catanzaro, Via Spasari, 3, 88100 Catanzaro, Italy, Tel +39 09 6172 1214, Fax +39 09 6172 5095, Email 
<email>pietro.gareri@alice.it</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2010</year>
      </pub-date>
      <!--Dove Press titles changed from ppub to collections in 2009.
								Fake ppub written to satisfy Coll Date Type=ppub-->
      <pub-date pub-type="ppub">
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>7</day>
        <month>4</month>
        <year>2010</year>
      </pub-date>
      <volume>5</volume>
      <fpage>31</fpage>
      <lpage>35</lpage>
      <history>
        <date date-type="received">
          <day>24</day>
          <month>2</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2010 Ruotolo et al, publisher and licensee Dove Medical Press Ltd.</copyright-statement>
        <license>
          <license-p>This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Adrenal incidentaloma (AI) is a term applied to an accidentally discovered adrenal mass on imaging performed for reasons unrelated to adrenal pathology. The widespread application of abdominal imaging procedure has resulted in an increased frequency of clinically silent adrenal masses. Although most AIs are nonfunctioning benign adenomas, a multidisciplinary approach with biochemical and radiological evaluation is needed to characterize these lesions and identify patients who are at high risk for hormonal or malignant evolution. Herein, we describe a case of a 69-year-old man with a pain at the base of right chest. On the basis of clinical evaluation, biochemical analysis, as well as imaging procedures, a diagnosis of right adrenocortical carcinoma was made. The patient underwent medical treatment.</p>
      </abstract>
      <kwd-group>
        <kwd>adrenal incidentaloma</kwd>
        <kwd>adrenal mass</kwd>
        <kwd>adrenocortical carcinoma</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>The widespread use of imaging, particularly computed tomography (CT) and magnetic resonance imaging (MRI), during diagnostic testing or treatment for many clinical conditions, has resulted in the identification of previously unsuspected adrenal lesions defined as adrenal incidentalomas (AIs).<xref ref-type="bibr" rid="b1-cia-5-031">1</xref>,<xref ref-type="bibr" rid="b2-cia-5-031">2</xref> The assessment of AIs is aimed at deciding whether or not the tumor should be surgically removed,<xref ref-type="bibr" rid="b3-cia-5-031">3</xref> adrenalectomy being indicated in hormonal hypersecretory states (such as pheocromocytoma) and in potentially malignant lesions.<xref ref-type="bibr" rid="b4-cia-5-031">4</xref></p>
      <p>Adrenal cortical carcinoma (ACC) is a rare and heterogeneous malignancy with incompletely understood pathogenesis and poor prognosis.<xref ref-type="bibr" rid="b5-cia-5-031">5</xref> ACC can be functional or nonfunctional with regard to hormone synthesis and clinical features.</p>
      <p>We report the case of a 69-year-old man who was investigated for chest pain, with a right adrenal carcinoma identified by total body CT-scan and adrenal scintigraphy.</p>
    </sec>
    <sec sec-type="cases">
      <title>Case report</title>
      <p>A 69-year-old male was admitted to the Geriatric Unit of Catanzaro Hospital due to the onset of chest pain since few days, without other symptoms. Clinical examination and review of systems as well as family medical history were unremarkable. On clinical examination we found only a mild hepatomegaly and a reduction of vesicular murmur. In the past medical history, he reported a moderate increase of systolic and diastolic blood pressure which was controlled by weight reduction, salt restriction, and pharmacological therapy (ramipril plus hydrochlorothiazide 5/25 mg one tablet/day). In the present admission, blood pressure was 140/80 mmHg and heart rate 110 beats per min (bpm); patient&#x2019;s body mass index was 36.36 Kg/m<sup>2</sup>. Chest X-ray was negative and electrocardiogram (ECG) recorded a sinus tachycardia. Biochemical analyses were normal (<xref ref-type="table" rid="t1-cia-5-031">Table 1</xref>) as well as hormonal evaluation (<xref ref-type="table" rid="t2-cia-5-031">Table 2</xref>). We found only high levels of fibrinogen (697 mg/dL), lactate dehydrogenase (LDH; 758 U/L), &#x3B1;<sub>2</sub>-globulins (8.2%) (<xref ref-type="table" rid="t1-cia-5-031">Table 1</xref>).</p>
      <p>Following an abdominal ultrasound imaging (US), a 10-cm right adrenal lesion was identified (<xref ref-type="fig" rid="f1-cia-5-031">Figures 1</xref> and <xref ref-type="fig" rid="f2-cia-5-031">2</xref>). For this reason the patient underwent a total body CT-scan that revealed a 10-cm round, dense, heterogeneous enhancing lesion with irregular margins and inhomogeneous contrast enhancement of solid component after intravenous (iv) contrast medium. Local invasion (right liver lobe, renal hilus, and right diaphragm) and tumor extension into the inferior vena cava, as well as a tumor thrombus in the inferior vena cava and in the pulmonary arteries, were found. After 5 and 7 days, adrenal scintigraphy with iodocholesterol analogs showed a discordant pattern with absence of radiotracer uptake by the adrenal mass.</p>
      <p>On the basis of these findings a diagnosis of &#x201C;right adrenocortical carcinoma hormonally inactive&#x201D; was made. Due to the invasive nature of the tumor we chose to put the patient on single agent mitotane.</p>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Incidentally discovered adrenal masses are found more frequently, so that all clinicians need to be aware of their etiology since each case needs to be treated individually. Patient age, general conditions, and tumor extension have to be taken into account; they may suggest avoiding combination therapy with other cytotoxic drugs and surgical treatment.</p>
      <p>The true prevalence of AIs is unknown. Much of the information quoted is derived from autopsy series, in which the prevalence of undiagnosed adrenal masses ranges from 1.4% to 3%&#x2013;6%.<xref ref-type="bibr" rid="b6-cia-5-031">6</xref> These results resemble those emerging from imaging studies, in fact, the prevalence of AIs in daily radiological practice is up to 5% of CT examination performed for various reasons.<xref ref-type="bibr" rid="b7-cia-5-031">7</xref></p>
      <p>However, the prevalence of incidentally discovered adrenal masses increases with age, accounting for less than 1% in patients aged younger than 30 years, approximately 7% between the fifth and the seventh decades, and showing peak incidence in the sixth decade.<xref ref-type="bibr" rid="b8-cia-5-031">8</xref></p>
      <p>AI is not a single pathological entity. A recent study<xref ref-type="bibr" rid="b9-cia-5-031">9</xref> on the prevalence of incidental adrenal mass confirmed histologically, shows that adenomas and myelolipomas are the most common lesions, whereas adrenocortical carcinoma is about 0.1%.</p>
      <p>ACC is a rare malignancy (incidence 1&#x2013;2 per million people) and radiologic prevalence is clearly related to the size of the tumor, accounting for 2% of tumors that are 4 cm or less, 6% of tumors that are 4.1 to 6 cm, and 25% of tumors that are greater than 6 cm.<xref ref-type="bibr" rid="b10-cia-5-031">10</xref> Clinical presentation is heterogeneous and prognosis is variable but generally poor,<xref ref-type="bibr" rid="b11-cia-5-031">11</xref> in fact, overall, this neoplasia accounts for 0.02% to 0.2% of all cancer-related deaths, with a median survival of 18 months.</p>
      <p>Women are more often affected than men (ratio 1:5);<xref ref-type="bibr" rid="b12-cia-5-031">12</xref> this gender difference could be partly explained by the higher rate of diagnostic abdominal procedures recommended for women than men. The age distribution has two peaks: the first in childhood and the second in the fourth and fifth decade.<xref ref-type="bibr" rid="b13-cia-5-031">13</xref></p>
      <p>Pathogenesis was incompletely understood, mutation at the 17p13 locus, including the p53 tumor suppressor gene, is observed in about 25% of cases;<xref ref-type="bibr" rid="b14-cia-5-031">14</xref> furthermore, alterations of the 11p15 locus, leading to IGF-II overexpression are frequently observed<xref ref-type="bibr" rid="b15-cia-5-031">15</xref> compared to adenomas or normal adrenal cortex.</p>
      <p>Patients present hormonal excess (virilization in women and gynecomastia and testis atrophy in men),<xref ref-type="bibr" rid="b16-cia-5-031">16</xref> Cushing&#x2019;s syndrome, or local effect mass in hormonally inactive ACC (nausea, vomiting, abdominal and back pain).<xref ref-type="bibr" rid="b17-cia-5-031">17</xref></p>
      <p>Biochemical screening for tumor hypersecretion as well as imaging evaluation is mandatory in all adrenocortical carcinomas to define the most correct approach. In fact, in stages I&#x2013;II (localized or locally invasive tumor) complete tumor removal offers the best chance for cure by far,<xref ref-type="bibr" rid="b16-cia-5-031">16</xref> in particular a complete resection.<xref ref-type="bibr" rid="b18-cia-5-031">18</xref> In ACC sized more than 10 cm or with invasion of adjacent organs, local recurrence after surgery occurs in 40% of patients.<xref ref-type="bibr" rid="b19-cia-5-031">19</xref></p>
      <p>Our patient had an advanced tumor and diagnosis was belated due to the absence of hormonal excess symptoms. Considering our patient&#x2019;s age, general conditions (hypertension, sinus tachycardia, obesity), invasivity and prognosis of the neoplasm, and the possibility of intraoperative complications, even after the negativity of biochemical work up (<xref ref-type="table" rid="t2-cia-5-031">Table 2</xref>), we considered a medical therapy with mitotane.</p>
      <p>Although adrenalectomy is the method of choice for the management of patients with ACC, being also compatible with a complete tumor resection in the presence of a tumor thrombus in the inferior vena cava,<xref ref-type="bibr" rid="b20-cia-5-031">20</xref> medical treatment should be considered as an alternative to adrenalectomy in elderly patients, in those unwilling to undergo surgery, and in patients with comorbid conditions that preclude surgery.<xref ref-type="bibr" rid="b21-cia-5-031">21</xref> In fact, while the presence of tumor thrombus may necessitate cardiac bypass technique, the prognosis of ACC still remains poor even after surgery with an overall five-year survival rate ranging between 16% and 38% in different series.<xref ref-type="bibr" rid="b22-cia-5-031">22</xref> Moreover, survival is clearly related to the extent of disease.<xref ref-type="bibr" rid="b23-cia-5-031">23</xref></p>
      <p>Mitotane is the only adrenal-specific agent available for treatment of ACC, it exerts a specific cytotoxic effect on adrenocortical cells producing focal degeneration. In the first study on the efficacy of this therapy by Lim and colleagues,<xref ref-type="bibr" rid="b24-cia-5-031">24</xref> seven of 18 patients with ACC showed significant tumor regression; even more favorable was the report by Lubitz and colleagues,<xref ref-type="bibr" rid="b25-cia-5-031">25</xref> which described tumor regression in 61% of patients. A recent clinical review by Allolio and colleagues<xref ref-type="bibr" rid="b5-cia-5-031">5</xref> that analyzed the efficacy of mitotane treatment in advanced ACC, concluded that mitotane leads to an objective tumor regression in about 25% of cases.</p>
      <p>Although a complete response (or even cure) in patients with advanced ACC is extremely rare, long-term survival has been reported;<xref ref-type="bibr" rid="b26-cia-5-031">26</xref> in fact our patient is alive and in good clinical conditions six months after surgery.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Disclosure</bold>
        </p>
        <p>The authors report no conflicts of interest in this work.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="b1-cia-5-031">
        <label>1.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alexandraki</surname>
              <given-names>KI</given-names>
            </name>
            <name>
              <surname>Grossman</surname>
              <given-names>AB</given-names>
            </name>
          </person-group>
          <article-title>Adrenal incidentalomas: the &#x201C;rule of four&#x201D;</article-title>
          <source>Clin Med</source>
          <year>2008</year>
          <volume>8</volume>
          <fpage>201</fpage>
          <lpage>204</lpage>
          <pub-id pub-id-type="pmid">18478872</pub-id>
        </mixed-citation>
      </ref>
      <ref id="b2-cia-5-031">
        <label>2.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prinz</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Brooks</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Churchill</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Incidental asymptomatic adrenal masses detected by computed tomographic scanning. Is operation required?</article-title>
          <source>JAMA</source>
          <year>1982</year>
          <volume>248</volume>
          <fpage>701</fpage>
          <lpage>704</lpage>
          <pub-id pub-id-type="pmid">7097921</pub-id>
        </mixed-citation>
      </ref>
      <ref id="b3-cia-5-031">
        <label>3.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Singh</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Buch</surname>
              <given-names>HN</given-names>
            </name>
          </person-group>
          <article-title>Adrenal incidentaloma: evaluation and managment</article-title>
          <source>J Clin Pathol</source>
          <year>2008</year>
          <volume>61</volume>
          <fpage>1168</fpage>
          <lpage>1173</lpage>
          <pub-id pub-id-type="pmid">18955573</pub-id>
        </mixed-citation>
      </ref>
      <ref id="b4-cia-5-031">
        <label>4.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grumbach</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Biller</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Brownstein</surname>
              <given-names>GD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Management of the clinically in apparent adrenal mass (incidentaloma)</article-title>
          <source>Ann Intern Med</source>
          <year>2003</year>
          <volume>138</volume>
          <fpage>424</fpage>
          <lpage>429</lpage>
          <pub-id pub-id-type="pmid">12614096</pub-id>
        </mixed-citation>
      </ref>
      <ref id="b5-cia-5-031">
        <label>5.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Allolio</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Fassnacht</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Clinical review: adrenocortical carcinoma: clinical update</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2006</year>
          <volume>91</volume>
          <fpage>2027</fpage>
          <lpage>2037</lpage>
          <pub-id pub-id-type="pmid">16551738</pub-id>
        </mixed-citation>
      </ref>
      <ref id="b6-cia-5-031">
        <label>6.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mansmann</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lau</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Balk</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rothberg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Miyachi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Bornstein</surname>
              <given-names>SR</given-names>
            </name>
          </person-group>
          <article-title>The clinically inapparent adrenal mass: update in the diagnosis and management</article-title>
          <source>Endocr Rev</source>
          <year>2004</year>
          <volume>25</volume>
          <fpage>309</fpage>
          <lpage>340</lpage>
          <pub-id pub-id-type="pmid">15082524</pub-id>
        </mixed-citation>
      </ref>
      <ref id="b7-cia-5-031">
        <label>7.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kloos</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Gross</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Francis</surname>
              <given-names>IR</given-names>
            </name>
            <name>
              <surname>Korobkin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shapiro</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Incidentally discovered adrenal masses</article-title>
          <source>Endocr Rev</source>
          <year>1995</year>
          <volume>16</volume>
          <fpage>460</fpage>
          <lpage>484</lpage>
          <pub-id pub-id-type="pmid">8521790</pub-id>
        </mixed-citation>
      </ref>
      <ref id="b8-cia-5-031">
        <label>8.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barzon</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Boscaro</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis and management of adrenal incidentalomas</article-title>
          <source>J Urol</source>
          <year>2000</year>
          <volume>163</volume>
          <fpage>398</fpage>
          <lpage>407</lpage>
          <pub-id pub-id-type="pmid">10647642</pub-id>
        </mixed-citation>
      </ref>
      <ref id="b9-cia-5-031">
        <label>9.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Song</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Chaudry</surname>
              <given-names>FS</given-names>
            </name>
            <name>
              <surname>Mayo-Smith</surname>
              <given-names>WW</given-names>
            </name>
          </person-group>
          <article-title>The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy</article-title>
          <source>AJR Am J Roentgenol</source>
          <year>2008</year>
          <volume>190</volume>
          <fpage>1163</fpage>
          <lpage>1168</lpage>
          <pub-id pub-id-type="pmid">18430826</pub-id>
        </mixed-citation>
      </ref>
      <ref id="b10-cia-5-031">
        <label>10.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vierhapper</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Heinze</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gessl</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Exner</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Adrenocortical tumors; prevalence of impaired glucose tolerance and of &#x201C;Paradoxical Rise&#x201D; of cortisol during an oral glucose tolerance test</article-title>
          <source>Exp Clin Endocrinol Diabetes</source>
          <year>2003</year>
          <volume>111</volume>
          <fpage>415</fpage>
          <lpage>420</lpage>
          <pub-id pub-id-type="pmid">14614648</pub-id>
        </mixed-citation>
      </ref>
      <ref id="b11-cia-5-031">
        <label>11.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stratakis</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Chrousos</surname>
              <given-names>GP</given-names>
            </name>
          </person-group>
          <article-title>Adrenal cancer</article-title>
          <source>Endocrinol Metab Clin North Am</source>
          <year>2000</year>
          <volume>29</volume>
          <fpage>15</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="pmid">10732261</pub-id>
        </mixed-citation>
      </ref>
      <ref id="b12-cia-5-031">
        <label>12.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Del Gaudio</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Del Gaudio</surname>
              <given-names>GA</given-names>
            </name>
          </person-group>
          <article-title>Virilizing adrenocortical tumors in adult woman. Report of 10 patients, 2 of whom each had a tumor secreting only testosterone</article-title>
          <source>Cancer</source>
          <year>1993</year>
          <volume>72</volume>
          <fpage>1997</fpage>
          <lpage>2003</lpage>
          <pub-id pub-id-type="pmid">8364880</pub-id>
        </mixed-citation>
      </ref>
      <ref id="b13-cia-5-031">
        <label>13.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wooten</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>DK</given-names>
            </name>
          </person-group>
          <article-title>Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature</article-title>
          <source>Cancer</source>
          <year>1993</year>
          <volume>72</volume>
          <fpage>3145</fpage>
          <lpage>3155</lpage>
          <pub-id pub-id-type="pmid">8242539</pub-id>
        </mixed-citation>
      </ref>
      <ref id="b14-cia-5-031">
        <label>14.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reincke</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Karl</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Travis</surname>
              <given-names>WH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>P53 mutations in human adrenocortical neoplasms: Immunohistochemical and molecoular studies</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>1994</year>
          <volume>78</volume>
          <fpage>790</fpage>
          <lpage>794</lpage>
          <pub-id pub-id-type="pmid">8126158</pub-id>
        </mixed-citation>
      </ref>
      <ref id="b15-cia-5-031">
        <label>15.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heppner</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Reincke</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Agarwal</surname>
              <given-names>SK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MEN1 gene analysis in sporadic adrenocortical neoplasms</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>1999</year>
          <volume>84</volume>
          <fpage>216</fpage>
          <lpage>219</lpage>
          <pub-id pub-id-type="pmid">9920087</pub-id>
        </mixed-citation>
      </ref>
      <ref id="b16-cia-5-031">
        <label>16.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vassilopoulou-Sellin</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Schultz</surname>
              <given-names>PN</given-names>
            </name>
          </person-group>
          <article-title>Adrenocortical carcinoma. Clinical outcome at the end of the 20th century</article-title>
          <source>Cancer</source>
          <year>2001</year>
          <volume>92</volume>
          <fpage>1113</fpage>
          <lpage>1121</lpage>
          <pub-id pub-id-type="pmid">11571723</pub-id>
        </mixed-citation>
      </ref>
      <ref id="b17-cia-5-031">
        <label>17.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Crucitti</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bellantone</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ferrante</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bischerini</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Crucitti</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>The italian registry for adrenal cortical carcinoma: analysis of a multiinstitutional series of 129 patients. The ACC Italian registry study group</article-title>
          <source>Surgery</source>
          <year>1996</year>
          <volume>119</volume>
          <fpage>161</fpage>
          <lpage>170</lpage>
          <pub-id pub-id-type="pmid">8571201</pub-id>
        </mixed-citation>
      </ref>
      <ref id="b18-cia-5-031">
        <label>18.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bodie</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Novick</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Pontes</surname>
              <given-names>JE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Cleveland clinic experience with adrenal cortical carcinoma</article-title>
          <source>J Urol</source>
          <year>1989</year>
          <volume>141</volume>
          <fpage>257</fpage>
          <lpage>260</lpage>
          <pub-id pub-id-type="pmid">2913342</pub-id>
        </mixed-citation>
      </ref>
      <ref id="b19-cia-5-031">
        <label>19.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Porte</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Siat</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Guibert</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Resection of adrenal metastases from non-small cell lung cancer: a multicenter study</article-title>
          <source>Ann Thorac Surg</source>
          <year>2001</year>
          <volume>71</volume>
          <fpage>981</fpage>
          <lpage>985</lpage>
          <pub-id pub-id-type="pmid">11269485</pub-id>
        </mixed-citation>
      </ref>
      <ref id="b20-cia-5-031">
        <label>20.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mantero</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Terzolo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Arnaldi</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A survey on adrenal incidentaloma in Italy</article-title>
          <source>Clin Endocr Metab</source>
          <year>2000</year>
          <volume>85</volume>
          <issue>2</issue>
          <fpage>637</fpage>
          <lpage>644</lpage>
        </mixed-citation>
      </ref>
      <ref id="b21-cia-5-031">
        <label>21.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haak</surname>
              <given-names>HO</given-names>
            </name>
            <name>
              <surname>Hermans</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>van de Velde</surname>
              <given-names>CJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients</article-title>
          <source>Br J Cancer</source>
          <year>1994</year>
          <volume>69</volume>
          <fpage>947</fpage>
          <lpage>951</lpage>
          <pub-id pub-id-type="pmid">8180029</pub-id>
        </mixed-citation>
      </ref>
      <ref id="b22-cia-5-031">
        <label>22.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Icard</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Goudet</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Charpenay</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adrenocortical carcinoma: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons Study Group</article-title>
          <source>World J Surg</source>
          <year>2001</year>
          <volume>25</volume>
          <fpage>891</fpage>
          <lpage>897</lpage>
          <pub-id pub-id-type="pmid">11572030</pub-id>
        </mixed-citation>
      </ref>
      <ref id="b23-cia-5-031">
        <label>23.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wajchenberg</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Albergaria</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Medonca</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adrenocortical carcinoma: clinical and laboratory observations</article-title>
          <source>Cancer</source>
          <year>2000</year>
          <volume>88</volume>
          <fpage>711</fpage>
          <lpage>736</lpage>
          <pub-id pub-id-type="pmid">10679640</pub-id>
        </mixed-citation>
      </ref>
      <ref id="b24-cia-5-031">
        <label>24.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lim</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Tan</surname>
              <given-names>YO</given-names>
            </name>
            <name>
              <surname>Chong</surname>
              <given-names>PY</given-names>
            </name>
            <name>
              <surname>Cheah</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>Treatment of adrenal cortical carcinoma with mitotane: outcome and complications</article-title>
          <source>Ann Acad Med Singapore</source>
          <year>1990</year>
          <volume>19</volume>
          <fpage>540</fpage>
          <lpage>544</lpage>
          <pub-id pub-id-type="pmid">2171414</pub-id>
        </mixed-citation>
      </ref>
      <ref id="b25-cia-5-031">
        <label>25.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lubitz</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Freeman</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Okun</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Mitotane use in inoperable adrenal cortical carcinoma</article-title>
          <source>JAMA</source>
          <year>1973</year>
          <volume>223</volume>
          <fpage>1109</fpage>
          <lpage>1112</lpage>
          <pub-id pub-id-type="pmid">4739370</pub-id>
        </mixed-citation>
      </ref>
      <ref id="b26-cia-5-031">
        <label>26.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Allolio</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Hahner</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Weismann</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Fassnacht</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Management of adrenocortical carcinoma</article-title>
          <source>Clin Endocrinol (Oxf)</source>
          <year>2004</year>
          <volume>60</volume>
          <fpage>273</fpage>
          <lpage>287</lpage>
          <pub-id pub-id-type="pmid">15008991</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1-cia-5-031" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Abdominal computed tomography shows a 10-cm right adrenal lesion.</p>
      </caption>
      <graphic xlink:href="cia-5-031f1"/>
    </fig>
    <fig id="f2-cia-5-031" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Abdominal computed tomography shows a 10-cm right adrenal lesion.</p>
      </caption>
      <graphic xlink:href="cia-5-031f2"/>
    </fig>
    <table-wrap id="t1-cia-5-031" position="float">
      <label>Table 1</label>
      <caption>
        <p>Biochemical evaluation</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th valign="middle" align="left" rowspan="1" colspan="1"/>
            <th valign="middle" align="left" rowspan="1" colspan="1"/>
            <th valign="middle" align="left" rowspan="1" colspan="1">
              <bold>NV</bold>
            </th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">RBC</td>
            <td valign="top" align="left" rowspan="1" colspan="1">4.2 &#xD7; 10<sup>6</sup>/mm<sup>3</sup></td>
            <td valign="top" align="left" rowspan="1" colspan="1">4.15&#x2013;4.9 &#xD7; 10<sup>6</sup>/mm<sup>3</sup></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">MCH</td>
            <td valign="top" align="left" rowspan="1" colspan="1">30 pg/cell</td>
            <td valign="top" align="left" rowspan="1" colspan="1">28&#x2013;33 pg/cell</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">MCHC</td>
            <td valign="top" align="left" rowspan="1" colspan="1">34 g/dL</td>
            <td valign="top" align="left" rowspan="1" colspan="1">32&#x2013;36 g/dL</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">MCV</td>
            <td valign="top" align="left" rowspan="1" colspan="1">88 &#x3BC;m<sup>3</sup></td>
            <td valign="top" align="left" rowspan="1" colspan="1">86&#x2013;98 &#x3BC;m<sup>3</sup></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">HCT</td>
            <td valign="top" align="left" rowspan="1" colspan="1">44%</td>
            <td valign="top" align="left" rowspan="1" colspan="1">42%&#x2013;52%</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Hemoglobin</td>
            <td valign="top" align="left" rowspan="1" colspan="1">15 g/dL</td>
            <td valign="top" align="left" rowspan="1" colspan="1">13&#x2013;18 g/dL</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">WBC</td>
            <td valign="top" align="left" rowspan="1" colspan="1">4.5 &#xD7; 10<sup>3</sup>/mm<sup>3</sup></td>
            <td valign="top" align="left" rowspan="1" colspan="1">4.3&#x2013;10.8 &#xD7; 10<sup>3</sup>/mm<sup>3</sup></td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">N</td>
            <td valign="top" align="left" rowspan="1" colspan="1">50%</td>
            <td valign="top" align="left" rowspan="1" colspan="1">45%&#x2013;75%</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">L</td>
            <td valign="top" align="left" rowspan="1" colspan="1">20%</td>
            <td valign="top" align="left" rowspan="1" colspan="1">16%&#x2013;45%</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">M</td>
            <td valign="top" align="left" rowspan="1" colspan="1">5%</td>
            <td valign="top" align="left" rowspan="1" colspan="1">4%&#x2013;10%</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">E</td>
            <td valign="top" align="left" rowspan="1" colspan="1">2%</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0%&#x2013;7%</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">B</td>
            <td valign="top" align="left" rowspan="1" colspan="1">1%</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0%&#x2013;2%</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Albumin</td>
            <td valign="top" align="left" rowspan="1" colspan="1">50%</td>
            <td valign="top" align="left" rowspan="1" colspan="1">50%&#x2013;60%</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">&#x3B1;1-globulins</td>
            <td valign="top" align="left" rowspan="1" colspan="1">5%</td>
            <td valign="top" align="left" rowspan="1" colspan="1">4.2%&#x2013;7.2%</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">&#x3B1;2-globulins</td>
            <td valign="top" align="left" rowspan="1" colspan="1">8.2%</td>
            <td valign="top" align="left" rowspan="1" colspan="1">6&#x2013;7.8%</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">&#x3B2;-globulins</td>
            <td valign="top" align="left" rowspan="1" colspan="1">11%</td>
            <td valign="top" align="left" rowspan="1" colspan="1">9.3%&#x2013;15%</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">&#x3B3;-globulins</td>
            <td valign="top" align="left" rowspan="1" colspan="1">15%</td>
            <td valign="top" align="left" rowspan="1" colspan="1">13%&#x2013;23%</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">AST</td>
            <td valign="top" align="left" rowspan="1" colspan="1">20 U/L</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0&#x2013;35 U/L</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">ALT</td>
            <td valign="top" align="left" rowspan="1" colspan="1">24 U/L</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0&#x2013;35 U/L</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Total bilirubin</td>
            <td valign="top" align="left" rowspan="1" colspan="1">1 mg/dL</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.3&#x2013;1.0 mg/dL</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">&#x2003;&#x2003;Direct</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.3 mg/dL</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.1&#x2013;0.3 mg/dL</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">&#x2003;&#x2003;Indirect</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.7 mg/dL</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.2&#x2013;0.7 mg/dL</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Glycemia</td>
            <td valign="top" align="left" rowspan="1" colspan="1">110 mg/dL</td>
            <td valign="top" align="left" rowspan="1" colspan="1">70&#x2013;115 mg/dL</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Cholesterol</td>
            <td valign="top" align="left" rowspan="1" colspan="1">220 mg/dL</td>
            <td valign="top" align="left" rowspan="1" colspan="1">220&#x2013;239 mg/dL</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">&#x2003;&#x2003;LDL</td>
            <td valign="top" align="left" rowspan="1" colspan="1">110 mg/dL</td>
            <td valign="top" align="left" rowspan="1" colspan="1">&lt;130 mg/dL</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">&#x2003;&#x2003;HDL</td>
            <td valign="top" align="left" rowspan="1" colspan="1">60 mg/dL</td>
            <td valign="top" align="left" rowspan="1" colspan="1">&gt;50 mg/dL</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Iron</td>
            <td valign="top" align="left" rowspan="1" colspan="1">80 &#x3BC;g/d</td>
            <td valign="top" align="left" rowspan="1" colspan="1">50&#x2013;150 &#x3BC;g/d</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Creatinine</td>
            <td valign="top" align="left" rowspan="1" colspan="1">1 mg/dL</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.8&#x2013;1.2 mg/dL</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">BUN</td>
            <td valign="top" align="left" rowspan="1" colspan="1">15 mg/dL</td>
            <td valign="top" align="left" rowspan="1" colspan="1">10&#x2013;20 mg/dL</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Uric acid</td>
            <td valign="top" align="left" rowspan="1" colspan="1">6 mg/dL</td>
            <td valign="top" align="left" rowspan="1" colspan="1">2.5&#x2013;8.0 mg/dL</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Fibrinogen</td>
            <td valign="top" align="left" rowspan="1" colspan="1">697 mg/dL</td>
            <td valign="top" align="left" rowspan="1" colspan="1">200&#x2013;450 mg/dL</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Sodium</td>
            <td valign="top" align="left" rowspan="1" colspan="1">140 mEq/L</td>
            <td valign="top" align="left" rowspan="1" colspan="1">135&#x2013;145 mEq/L</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Potassium</td>
            <td valign="top" align="left" rowspan="1" colspan="1">4 mEq/L</td>
            <td valign="top" align="left" rowspan="1" colspan="1">3.5&#x2013;5.0 mEq/L</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Calcium</td>
            <td valign="top" align="left" rowspan="1" colspan="1">9 mg/dL</td>
            <td valign="top" align="left" rowspan="1" colspan="1">9&#x2013;10.5 mg/dL</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">LDH</td>
            <td valign="top" align="left" rowspan="1" colspan="1">758 U/L</td>
            <td valign="top" align="left" rowspan="1" colspan="1">100&#x2013;190 U/L</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tfn1-cia-5-031">
          <p><bold>Abbreviations:</bold> RBC, red blood cells; MCH, mean corpuscolar hemoglobin; MCHC, mean corpuscolar hemoglobin concentration; MCV, mean corpuscolar volume; HCT, hematocrit; WBC, white blood cells; N, neutrophils; L, lymphocytes; M, monocytes; e, eosinophils; B, basophils; AST, aspartate tranaminase; ALT, alanine transaminase; LDL, low density lipoproteins; HDL, high density lipoproteins; BUN, blood urea nitrogen; LDH, lactate dehydrogenase; NV, normal values.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="t2-cia-5-031" position="float">
      <label>Table 2</label>
      <caption>
        <p>Endocrine work-up</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th valign="middle" align="left" rowspan="1" colspan="1"/>
            <th valign="middle" align="left" rowspan="1" colspan="1"/>
            <th valign="middle" align="left" rowspan="1" colspan="1">
              <bold>NV</bold>
            </th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Cortisol</td>
            <td valign="top" align="left" rowspan="1" colspan="1">164.3 ng/mL</td>
            <td valign="top" align="left" rowspan="1" colspan="1">50&#x2013;250 ng/mL</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Renin</td>
            <td valign="top" align="left" rowspan="1" colspan="1">2 ng/mL/h</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.3&#x2013;3.0 ng/ml/h</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Aldosteron</td>
            <td valign="top" align="left" rowspan="1" colspan="1">10 &#x3BC;g/dL</td>
            <td valign="top" align="left" rowspan="1" colspan="1">5&#x2013;19 &#x3BC;g/dL</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">ACTH</td>
            <td valign="top" align="left" rowspan="1" colspan="1">16 pg/mL</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0&#x2013;46 pg/mL</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Epinephrine</td>
            <td valign="top" align="left" rowspan="1" colspan="1">35 &#x3BC;g/d</td>
            <td valign="top" align="left" rowspan="1" colspan="1">&lt;50 &#x3BC;g/d</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Norepinephrine</td>
            <td valign="top" align="left" rowspan="1" colspan="1">60 &#x3BC;g/dL</td>
            <td valign="top" align="left" rowspan="1" colspan="1">15&#x2013;80 &#x3BC;g/dL</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Overnight dexamethasone suppressor test</td>
            <td valign="top" align="left" rowspan="1" colspan="1">3 &#x3BC;g/dL</td>
            <td valign="top" align="left" rowspan="1" colspan="1">&lt;5 &#x3BC;g/dL</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tfn2-cia-5-031">
          <p><bold>Abbreviations:</bold> ACTH, adrenocorticotropic hormone (corticotropin); NV, normal values.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
